U-Chart Analysis:ASKA Pharmaceutical Co.,Ltd.:4514

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ASKA Pharmaceutical Co.,Ltd. Go to web site 4514 Medicals 1st TSE March 1, 2000 1955.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ASKA Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents 7,294 10,982 10,221 14,761 5,462
Other Current AssetsHelp 30,032 26,847 24,597 22,298 21,416
Tangible Fixed AssetsHelp 13,539 13,573 12,129 12,829 13,801
Intangible Fixed AssetHelp 9,368 9,598 1,140 3,491 368
Investments and OthersHelp 20,006 21,194 13,932 7,013 14,212
Total AssetsHelp 80,239 82,194 66,235 66,126 57,478
Total Current LiabilitiesHelp 24,995 25,768 21,926 24,115 18,267
Total Long-term LiabilitiesHelp 13,671 12,970 1,750 2,500 3,250
Shareholder's EquityHelp 41,573 43,456 42,559 39,511 35,961
Total LiabilitiesHelp 80,239 82,194 66,235 66,126 57,478

ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales 52,542 46,706 48,944 48,527 43,215
Total Sales 52,542 46,706 48,944 48,527 43,215
Cost of SalesHelp 28,525 27,814 30,059 29,614 26,072
Other Costs and RevenueHelp 23,368 17,148 16,497 15,969 16,441
Total CostsHelp 51,893 44,962 46,556 45,583 42,513
Net RevenueHelp 24,017 18,892 18,885 18,913 17,143
Earnings Before TaxHelp 901 1,883 3,063 3,300 1,448
Net IncomeHelp 649 1,744 2,388 2,944 702
Net Income 649 1,744 2,388 2,944 702

ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help -493 2,504 75 12,061 -1,349
Investing Cash Flow(ICF)Help -2,927 -14,780 -3,348 -378 -6,776
Financing Cash FlowHelp -392 13,036 -1,142 -2,384 4,013
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -3,812 760 -4,415 9,299 -4,112

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ASKA Pharmaceutical Co.,Ltd.

Company where related level is highHelp

SAWAI PHARMACEUTICAL CO.,LTD.
UMN Pharma Inc.
Fuso Pharmaceutical Industries, Ltd.
D.Western Therapeutics Institute, Inc.
Otsuka Holdings Co.,Ltd.
DAIICHI SANKYO COMPANY,LIMITED
NISSUI PHARMACEUTICAL CO.,LTD.
TSUMURA & CO.
Nichi-Iko Pharmaceutical Co.,Ltd.
ASKA Pharmaceutical Co.,Ltd.